G. Ralph Corey, MD
Duke University
7
7
7
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Seetha Shankaran, MD
Wayne State University
Shared therapeutic areas:
Dale L. Phelps, MD
University of Rochester
Shared therapeutic areas:
Abhik Das, PhD
RTI International
Shared therapeutic areas:
Michele C. Walsh, MD MS
Case Western Reserve University, Rainbow Babies and Children's Hospital
Shared therapeutic areas:
Asem A Elfert, MD
Tanta Faculty of Medicine, Professor
Shared therapeutic areas:
Ivan D. Frantz III, MD
Tufts Medical Center
Shared therapeutic areas:
Saad Nseir, MD,PhD
University Hospital, Lille
Shared therapeutic areas:
Barbara J. Stoll, MD
Emory University
Shared therapeutic areas:
Jeffrey L Schnipper, MD, MPH
Brigham and Women's Hospital
Shared therapeutic areas:
Prema Dhanraj, MS, MCh
Rajarajeshwari Medical College and Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia
Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus
Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus
Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
All 7 trials loaded